Intratympanic methylprednisolone for sudden sensorineural hearing loss
dc.contributor.author | Kılıç, Rahmi | |
dc.contributor.author | Safak, Mustafa Asim | |
dc.contributor.author | Oguz, Haldun | |
dc.contributor.author | Kargin, Selda | |
dc.contributor.author | Demirci, Munir | |
dc.contributor.author | Samim, Erdal | |
dc.contributor.author | Ozluoglu, Levent Naci | |
dc.date.accessioned | 2020-06-25T17:43:53Z | |
dc.date.available | 2020-06-25T17:43:53Z | |
dc.date.issued | 2007 | |
dc.description | Kaytez, Selda Kargin/0000-0002-8683-7076; OZLUOGLU, LEVENT NACI/0000-0002-2150-0237 | |
dc.description.abstract | Objective: Corticosteroids are commonly used for the treatment of sudden sensorineural hearing loss (SSHL). In this study, the effectiveness of intratympanic (IT) corticosteroid injection was studied and compared with a control group on patients with SSHL who failed systemic corticosteroid treatment. Materials and Methods: A total of 19 patients as a retreatment group (RG) and 18 patients as a control group (CG), all failed high-dose intravenous and oral corticosteroid treatments, were included in this study. These patients were invited back, and IT methylprednisolone was injected five times via 3-day intervals in RG and followed-up for a mean period of 24.9 months (range, 7-30 mo). Audiological evaluations were performed initially, a week after the completion of the injections, monthly in the following first 3 months, and at the end of follow-up period in RG. The CG was followed-up for 3 months after the completion of systemic corticosteroid treatment without any additional drug administration. Results: The mean age was 52.6 years (range, 20-79 yr) in RG and 59.9 years in CG. The mean pure-tone average for speech frequencies (500-4,000 Hz) at baseline audiogram and at the first month, at the third month, and at last controls were 65.2 (range, 43-102 dB), 45.4 (range, 23-77 dB), 43.6 (range, 30-77 dB), and 44.5 (range, 33-77 dB) dB, respectively, in RG. The mean pure-tone averages for speech frequencies (500-4,000 Hz) at the end of systemic treatment and at third-month control were 63.5 (range, 44-98 dB) and 59.0 (range, 40-100 dB) dB, respectively, in CG. The hearing gain that is equal to or more than 10 dB was achieved in 14 patients (73.6%) at the last control in RG. No hearing gain could be detected in the CG. No serious side effect was observed with IT treatment. Conclusion: We conclude that IT methylprednisolone injection provides more significant hearing improvement for patients that failed with previous high-dose systemic corticosteroid administration than systemic corticosteroid treatment alone. So it may be the first-step medical treatment of idiopathic SSHL alone or at least may be combined with the systemic corticosteroid administration. | en_US |
dc.identifier.citation | closedAccess | en_US |
dc.identifier.doi | 10.1097/MAO.0b013e31802fba7a | |
dc.identifier.endpage | 316 | en_US |
dc.identifier.issn | 1531-7129 | |
dc.identifier.issn | 1537-4505 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 17414035 | |
dc.identifier.scopus | 2-s2.0-34247216692 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 312 | en_US |
dc.identifier.uri | https://doi.org10.1097/MAO.0b013e31802fba7a | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/3936 | |
dc.identifier.volume | 28 | en_US |
dc.identifier.wos | WOS:000245401500004 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Otology & Neurotology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | corticosteroid | en_US |
dc.subject | intratympanic | en_US |
dc.subject | sudden heating loss | en_US |
dc.subject | treatment | en_US |
dc.title | Intratympanic methylprednisolone for sudden sensorineural hearing loss | en_US |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
[ X ]
- İsim:
- Intratympanic methylprednisolone for sudden sensorineural hearing loss.pdf
- Boyut:
- 106.6 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin/Full Text